{"id":"https://openalex.org/W71748888","doi":null,"title":"LY-2140023, a prodrug of the group II metabotropic glutamate receptor agonist LY-404039 for the potential treatment of schizophrenia.","display_name":"LY-2140023, a prodrug of the group II metabotropic glutamate receptor agonist LY-404039 for the potential treatment of schizophrenia.","publication_year":2010,"publication_date":"2010-07-01","ids":{"openalex":"https://openalex.org/W71748888","mag":"71748888","pmid":"https://pubmed.ncbi.nlm.nih.gov/20571979"},"language":"en","primary_location":{"id":"pmid:20571979","doi":null,"is_oa":false,"landing_page_url":"https://pubmed.ncbi.nlm.nih.gov/20571979","pdf_url":null,"source":{"id":"https://openalex.org/S4306525036","display_name":"PubMed","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Current opinion in investigational drugs (London, England : 2000)","raw_type":"Clinical Trial, Phase II"},"volume":null,"type":"article","indexed_in":["pubmed"],"open_access":{"is_oa":false,"oa_status":"closed","oa_url":null,"any_repository_has_fulltext":false},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5055340761","display_name":"Mario Mezler","orcid":"https://orcid.org/0000-0002-7253-0962","observed_orcids":["https://orcid.org/0000-0002-7253-0962"]},"institutions":[{"id":"https://openalex.org/I4210088555","display_name":"Abbott (United States)","ror":"https://ror.org/0052svj16","country_code":"US","type":"company","lineage":["https://openalex.org/I4210088555"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Mario Mezler","raw_affiliation_strings":["Abbott Laboratories, Global Pharmaceutical Research and Development, Neuroscience Clinical Development, Abbott Park, IL 60064-6075, USA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Abbott Laboratories, Global Pharmaceutical Research and Development, Neuroscience Clinical Development, Abbott Park, IL 60064-6075, USA","institution_ids":["https://openalex.org/I4210088555"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5063485942","display_name":"Herv\u00e9 Geneste","orcid":"https://orcid.org/0000-0002-2808-1573","observed_orcids":["https://orcid.org/0000-0002-2808-1573"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Herv\u00e9 Geneste","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]},{"author_position":"middle","author":{"id":"https://openalex.org/A5036372932","display_name":"Laura M. Gault","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Laura Gault","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]},{"author_position":"last","author":{"id":"https://openalex.org/A5004332028","display_name":"Gerard J. Marek","orcid":"https://orcid.org/0000-0001-8103-4306","observed_orcids":["https://orcid.org/0000-0001-8103-4306"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Gerard J Marek","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]}],"institutions":[],"countries_distinct_count":1,"institutions_distinct_count":1,"corresponding_author_ids":[],"corresponding_institution_ids":[],"apc_list":null,"apc_paid":null,"fwci":4.3805,"has_fulltext":false,"cited_by_count":47,"citation_normalized_percentile":{"value":0.94115013,"is_in_top_1_percent":false,"is_in_top_10_percent":true},"cited_by_percentile_year":{"min":89,"max":99},"biblio":{"volume":"11","issue":"7","first_page":"833","last_page":"45"},"is_retracted":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T10023","display_name":"Schizophrenia research and treatment","score":0.9550999999046326,"subfield":{"id":"https://openalex.org/subfields/2738","display_name":"Psychiatry and Mental health"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},"topics":[{"id":"https://openalex.org/T10023","display_name":"Schizophrenia research and treatment","score":0.9550999999046326,"subfield":{"id":"https://openalex.org/subfields/2738","display_name":"Psychiatry and Mental health"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T10077","display_name":"Neuroscience and Neuropharmacology Research","score":0.030799999833106995,"subfield":{"id":"https://openalex.org/subfields/2804","display_name":"Cellular and Molecular Neuroscience"},"field":{"id":"https://openalex.org/fields/28","display_name":"Neuroscience"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},{"id":"https://openalex.org/T12770","display_name":"Amino Acid Enzymes and Metabolism","score":0.003800000064074993,"subfield":{"id":"https://openalex.org/subfields/1303","display_name":"Biochemistry"},"field":{"id":"https://openalex.org/fields/13","display_name":"Biochemistry, Genetics and Molecular Biology"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/prodrugs","display_name":"prodrugs","score":0.8199999928474426},{"id":"https://openalex.org/keywords/group-ii-metabotropic-glutamate-receptors","display_name":"group II metabotropic glutamate receptors","score":0.8579999804496765},{"id":"https://openalex.org/keywords/mglur2-3-agonist","display_name":"mGluR2/3 agonist","score":0.9549999833106995},{"id":"https://openalex.org/keywords/schizophrenia","display_name":"schizophrenia","score":0.8330000042915344},{"id":"https://openalex.org/keywords/antipsychotic-drugs","display_name":"antipsychotic drugs","score":0.8100000023841858},{"id":"https://openalex.org/keywords/extrapyramidal-symptoms","display_name":"extrapyramidal symptoms","score":0.9319999814033508},{"id":"https://openalex.org/keywords/atypical-antipsychotics","display_name":"atypical antipsychotics","score":0.7229999899864197},{"id":"https://openalex.org/keywords/prefrontal-cortex","display_name":"prefrontal cortex","score":0.6700000166893005},{"id":"https://openalex.org/keywords/striatum","display_name":"striatum","score":0.8289999961853027},{"id":"https://openalex.org/keywords/hippocampus","display_name":"hippocampus","score":0.8259999752044678},{"id":"https://openalex.org/keywords/thalamus","display_name":"thalamus","score":0.996999979019165}],"concepts":[{"id":"https://openalex.org/C119128870","wikidata":"https://www.wikidata.org/wiki/Q4859538","display_name":"Metabotropic glutamate receptor 2","level":5,"score":0.8953778743743896},{"id":"https://openalex.org/C49051014","wikidata":"https://www.wikidata.org/wiki/Q2033959","display_name":"Metabotropic glutamate receptor","level":4,"score":0.7883638143539429},{"id":"https://openalex.org/C98274493","wikidata":"https://www.wikidata.org/wiki/Q128406","display_name":"Pharmacology","level":1,"score":0.5942689180374146},{"id":"https://openalex.org/C41653306","wikidata":"https://www.wikidata.org/wiki/Q6589190","display_name":"Metabotropic glutamate receptor 5","level":5,"score":0.577316164970398},{"id":"https://openalex.org/C207951395","wikidata":"https://www.wikidata.org/wiki/Q288431","display_name":"Metabotropic glutamate receptor 1","level":5,"score":0.5242652893066406},{"id":"https://openalex.org/C87247309","wikidata":"https://www.wikidata.org/wiki/Q6590338","display_name":"Metabotropic glutamate receptor 7","level":5,"score":0.4770890176296234},{"id":"https://openalex.org/C26702167","wikidata":"https://www.wikidata.org/wiki/Q901988","display_name":"Metabotropic receptor","level":4,"score":0.4539312422275543},{"id":"https://openalex.org/C169760540","wikidata":"https://www.wikidata.org/wiki/Q207011","display_name":"Neuroscience","level":1,"score":0.452546089887619},{"id":"https://openalex.org/C2780494398","wikidata":"https://www.wikidata.org/wiki/Q208144","display_name":"Antipsychotic","level":3,"score":0.44614049792289734},{"id":"https://openalex.org/C2778938600","wikidata":"https://www.wikidata.org/wiki/Q389934","display_name":"Agonist","level":3,"score":0.43623432517051697},{"id":"https://openalex.org/C116592611","wikidata":"https://www.wikidata.org/wiki/Q21113349","display_name":"Metabotropic glutamate receptor 4","level":5,"score":0.43595802783966064},{"id":"https://openalex.org/C71924100","wikidata":"https://www.wikidata.org/wiki/Q11190","display_name":"Medicine","level":0,"score":0.4100441634654999},{"id":"https://openalex.org/C15744967","wikidata":"https://www.wikidata.org/wiki/Q9418","display_name":"Psychology","level":0,"score":0.3062824308872223},{"id":"https://openalex.org/C2776412080","wikidata":"https://www.wikidata.org/wiki/Q7431605","display_name":"Schizophrenia (object-oriented programming)","level":2,"score":0.29443585872650146},{"id":"https://openalex.org/C126322002","wikidata":"https://www.wikidata.org/wiki/Q11180","display_name":"Internal medicine","level":1,"score":0.23385360836982727},{"id":"https://openalex.org/C170493617","wikidata":"https://www.wikidata.org/wiki/Q208467","display_name":"Receptor","level":2,"score":0.21200460195541382},{"id":"https://openalex.org/C118552586","wikidata":"https://www.wikidata.org/wiki/Q7867","display_name":"Psychiatry","level":1,"score":0.16102173924446106}],"mesh":[{"descriptor_ui":"D000596","descriptor_name":"Amino Acids","qualifier_ui":"Q000009","qualifier_name":"adverse effects","is_major_topic":false},{"descriptor_ui":"D000596","descriptor_name":"Amino Acids","qualifier_ui":"Q000138","qualifier_name":"chemical synthesis","is_major_topic":false},{"descriptor_ui":"D000596","descriptor_name":"Amino Acids","qualifier_ui":"Q000493","qualifier_name":"pharmacokinetics","is_major_topic":false},{"descriptor_ui":"D000596","descriptor_name":"Amino Acids","qualifier_ui":"Q000494","qualifier_name":"pharmacology","is_major_topic":false},{"descriptor_ui":"D000596","descriptor_name":"Amino Acids","qualifier_ui":"Q000627","qualifier_name":"therapeutic use","is_major_topic":true},{"descriptor_ui":"D000818","descriptor_name":"Animals","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D003499","descriptor_name":"Cyclic S-Oxides","qualifier_ui":"Q000494","qualifier_name":"pharmacology","is_major_topic":true},{"descriptor_ui":"D006801","descriptor_name":"Humans","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D010330","descriptor_name":"Patents as Topic","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D011355","descriptor_name":"Prodrugs","qualifier_ui":"Q000627","qualifier_name":"therapeutic use","is_major_topic":true},{"descriptor_ui":"D013329","descriptor_name":"Structure-Activity Relationship","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D014150","descriptor_name":"Antipsychotic Agents","qualifier_ui":"Q000627","qualifier_name":"therapeutic use","is_major_topic":true},{"descriptor_ui":"D018094","descriptor_name":"Receptors, Metabotropic Glutamate","qualifier_ui":"Q000819","qualifier_name":"agonists","is_major_topic":true},{"descriptor_ui":"D019086","descriptor_name":"Bridged Bicyclo Compounds, Heterocyclic","qualifier_ui":"Q000494","qualifier_name":"pharmacology","is_major_topic":true}],"locations_count":2,"locations":[{"id":"pmid:20571979","doi":null,"is_oa":false,"landing_page_url":"https://pubmed.ncbi.nlm.nih.gov/20571979","pdf_url":null,"source":{"id":"https://openalex.org/S4306525036","display_name":"PubMed","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Current opinion in investigational drugs (London, England : 2000)","raw_type":"Clinical Trial, Phase II"},{"id":"mag:71748888","doi":null,"is_oa":false,"landing_page_url":"https://pubmed.ncbi.nlm.nih.gov/20571979","pdf_url":null,"source":{"id":"https://openalex.org/S4306525036","display_name":"PubMed","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":null,"is_accepted":false,"is_published":false,"raw_source_name":"PubMed","raw_type":null}],"best_oa_location":null,"sustainable_development_goals":[{"id":"https://metadata.un.org/sdg/3","score":0.9537000060081482,"display_name":"Good health and well-being"}],"study_designs":[],"awards":[],"funders":[],"has_content":{"grobid_xml":false,"pdf":false},"content_urls":null,"referenced_works_count":0,"referenced_works":[],"related_works":["https://openalex.org/W2116386279","https://openalex.org/W2089973430","https://openalex.org/W2113113845","https://openalex.org/W2026339278","https://openalex.org/W2077542428","https://openalex.org/W2090187096","https://openalex.org/W7098269630","https://openalex.org/W2312770619","https://openalex.org/W1989025308","https://openalex.org/W2033584117"],"abstract_inverted_index":{"LY-2140023":[0,153,174],"is":[1,30],"a":[2,31,91,127,140,176],"methionine":[3],"amide":[4],"prodrug":[5],"of":[6,27,61,66,76,107,123,130,168,184],"the":[7,23,58,72,95,105,111,118,155,166,182],"orthosteric":[8],"metabotropic":[9],"glutamate":[10,33,44],"receptor":[11],"(mGluR)2/3":[12],"agonist":[13],"LY-404039,":[14,77],"being":[15,185],"developed":[16,187],"by":[17,80,126],"Eli":[18],"Lilly":[19],"&":[20],"Co,":[21],"for":[22,134],"potential":[24],"oral":[25],"treatment":[26],"schizophrenia.":[28,150],"LY-404039":[29],"rigid":[32],"analog":[34],"that":[35,53,98,161,180],"selectively":[36],"binds":[37],"to":[38,101,190],"mGluR2/3":[39],"compared":[40],"with":[41,49,71,149,165],"all":[42],"other":[43,50],"receptors":[45,52],"and":[46,48,84,117,157],"transporters,":[47],"monoaminergic":[51],"have":[54],"been":[55,69],"implicated":[56],"in":[57,94,104,139,147],"therapeutic":[59],"efficacy":[60,122],"atypical":[62],"antipsychotic":[63,121,135,171],"drugs.":[64,172],"Activation":[65],"mGluR2":[67,88],"has":[68],"associated":[70],"antipsychotic-like":[73],"behavioral":[74,132],"effects":[75,160],"as":[78,90,110],"indicated":[79],"experiments":[81],"using":[82],"mGluR2-/-":[83],"mGluR3-/-":[85],"mice.":[86],"Furthermore,":[87],"acts":[89],"glutamatergic":[92],"autoreceptor":[93],"brain":[96],"regions":[97],"are":[99,162],"believed":[100],"be":[102],"important":[103],"pathophysiology":[106],"schizophrenia,":[108],"such":[109],"prefrontal":[112],"cortex,":[113],"striatum,":[114],"hippocampal":[115],"formation":[116],"thalamus.":[119],"The":[120],"LY-2140023,":[124],"predicted":[125],"common":[128],"battery":[129],"preclinical":[131],"screens":[133],"drugs,":[136],"was":[137],"confirmed":[138],"randomized,":[141],"placebo-controlled,":[142],"phase":[143],"II":[144],"clinical":[145],"trial":[146],"patients":[148],"In":[151],"addition,":[152],"lacked":[154],"extrapyramidal":[156],"metabolic":[158],"side":[159],"commonly":[163],"observed":[164],"majority":[167],"currently":[169],"approved":[170],"Thus,":[173],"represents":[175],"rare":[177],"psychiatric":[178],"medicine":[179],"demonstrates":[181],"promise":[183],"rationally":[186],"from":[188],"bench":[189],"bedside.":[191]},"counts_by_year":[{"year":2024,"cited_by_count":1},{"year":2022,"cited_by_count":2},{"year":2021,"cited_by_count":2},{"year":2020,"cited_by_count":4},{"year":2019,"cited_by_count":2},{"year":2018,"cited_by_count":3},{"year":2017,"cited_by_count":1},{"year":2016,"cited_by_count":4},{"year":2015,"cited_by_count":4},{"year":2014,"cited_by_count":3},{"year":2013,"cited_by_count":6},{"year":2012,"cited_by_count":8}],"updated_date":"2026-11-04T10:54:05.112534","created_date":"2016-06-24T00:00:00"}